Maria Sharapova removed from Women's Tennis RankingsSport October 24, 11:17
Developer shows first image of Russia's new Sarmat ballistic missileMilitary & Defense October 24, 10:15
Moody's revises outlook on Russia's banking system to ‘stable’Business & Economy October 24, 10:00
Russia and Belarus held joint airborne drills in BrestMilitary & Defense October 24, 8:16
District head: all people on board crashed helicopter in Transbaikal deadSociety & Culture October 24, 8:16
Kremlin ex-chief: Russia is ready to open new page in relations with US after electionsRussian Politics & Diplomacy October 24, 4:10
Russian inspectors to hold observation flight over TurkeyRussian Politics & Diplomacy October 24, 2:30
Steinmeier: Further anti-Russian sanctions may hamper talksWorld October 23, 23:31
Qatari former Emir Sheikh Khalifa bin Hamad Al Thani dies aged 84World October 23, 23:08
GENEVA, October 3. /TASS/. The Court of Arbitration for Sport (CAS) is set to announce a decision on the appeal of Russian tennis star Maria Sharapova, submitted in summer against her two-year ban, on Tuesday, October 4, the court said in its statement on Monday.
"Decision in the case of Maria Sharapova v. International Tennis Federation to be released at 3.00 pm (Swiss time) on 4 October 2016," the statement said.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was imposed on June 8 by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations.
Due to the imposed ban world’s former No. 1 Sharapova had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.